Omaxe Intrinsic Value
Omaxe intrinsic value. Omaxe (OMAXE) median intrinsic value is ₹107.37 from 3 valuation models (range ₹51–₹108), vs current price ₹99.31 — +8.1% upside (Trading Near Calculated Value), margin of safety 7.5%. Analyse Omaxe ownership pattern to track promoter, FII and institutional holdings.
OMAXE Valuation Methods Summary — DCF, Graham Number & P/E
Omaxe intrinsic value across 3 models vs current price ₹99.31 — upside/downside and value range per method. Browse OMAXE balance sheet details for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹107.37 | ₹96.63 - ₹118.11 | +8.1% | Revenue/Share: ₹134.21, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹51.15 | ₹46.03 - ₹56.27 | -48.5% | EBITDA: ₹156.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹107.55 | ₹86.04 - ₹129.06 | +8.3% | CF Growth: 5.0%, Discount: 15% |
OMAXE Intrinsic Value vs Market Price — All Valuation Models
Omaxe fair value range ₹51–₹108 vs current market price ₹99.31 across 3 valuation models. For current market price and key ratios, visit Omaxe screener.
OMAXE Intrinsic Value Analysis — Undervalued or Overvalued?
Omaxe median intrinsic value ₹107.37, current price ₹99.31 — Trading Near Calculated Value by 8.1%, margin of safety 7.5%.
What is the intrinsic value of OMAXE?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Omaxe (OMAXE) is ₹107.37 (median value). With the current market price of ₹99.31, this represents a +8.1% variance from our estimated fair value.
The valuation range spans from ₹51.15 to ₹107.55, indicating ₹51.15 - ₹107.55.
Is OMAXE undervalued or overvalued?
Based on our multi-method analysis, Omaxe (OMAXE) appears to be trading near calculated value by approximately 8.1%.
OMAXE Financial Health — Key Ratios vs Industry Benchmarks
Omaxe financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 11.6% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.15x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
OMAXE Cash Flow Quality — Operating & Free Cash Flow
Omaxe operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹212 Cr | ₹212 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹1,007 Cr | ₹944 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹987 Cr | ₹955 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹469 Cr | ₹398 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹783 Cr | ₹772 Cr | Positive Free Cash Flow | 8/10 |